These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 31746410)

  • 1. Differentially expressed microRNAs in exosomes of patients with breast cancer revealed by next‑generation sequencing.
    Wu H; Wang Q; Zhong H; Li L; Zhang Q; Huang Q; Yu Z
    Oncol Rep; 2020 Jan; 43(1):240-250. PubMed ID: 31746410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
    Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
    Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial.
    Stevic I; Müller V; Weber K; Fasching PA; Karn T; Marmé F; Schem C; Stickeler E; Denkert C; van Mackelenbergh M; Salat C; Schneeweiss A; Pantel K; Loibl S; Untch M; Schwarzenbach H
    BMC Med; 2018 Oct; 16(1):179. PubMed ID: 30301470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal miRNAs are potential diagnostic biomarkers between malignant and benign thyroid nodules based on next-generation sequencing.
    Pan Q; Zhao J; Li M; Liu X; Xu Y; Li W; Wu S; Su Z
    Carcinogenesis; 2020 Mar; 41(1):18-24. PubMed ID: 31560760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
    McAnena P; Tanriverdi K; Curran C; Gilligan K; Freedman JE; Brown JAL; Kerin MJ
    BMC Cancer; 2019 May; 19(1):436. PubMed ID: 31077182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating exosomal microRNAs as biomarkers of colon cancer.
    Ogata-Kawata H; Izumiya M; Kurioka D; Honma Y; Yamada Y; Furuta K; Gunji T; Ohta H; Okamoto H; Sonoda H; Watanabe M; Nakagama H; Yokota J; Kohno T; Tsuchiya N
    PLoS One; 2014; 9(4):e92921. PubMed ID: 24705249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer.
    McDermott AM; Miller N; Wall D; Martyn LM; Ball G; Sweeney KJ; Kerin MJ
    PLoS One; 2014; 9(1):e87032. PubMed ID: 24498016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of tRNA-derived small noncoding RNAs as potential biomarkers for prediction of recurrence in triple-negative breast cancer.
    Feng W; Li Y; Chu J; Li J; Zhang Y; Ding X; Fu Z; Li W; Huang X; Yin Y
    Cancer Med; 2018 Oct; 7(10):5130-5144. PubMed ID: 30239174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression profile of plasma exosomal microRNAs in women with polycystic ovary syndrome.
    Jiang X; Li J; Zhang B; Hu J; Ma J; Cui L; Chen ZJ
    Fertil Steril; 2021 Mar; 115(3):782-792. PubMed ID: 33041053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosome-Derived MiRNAs as Biomarkers of the Development and Progression of Intracranial Aneurysms.
    Liao B; Zhou MX; Zhou FK; Luo XM; Zhong SX; Zhou YF; Qin YS; Li PP; Qin C
    J Atheroscler Thromb; 2020 Jun; 27(6):545-610. PubMed ID: 31597886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
    Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
    Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks.
    Fish EJ; Irizarry KJ; DeInnocentes P; Ellis CJ; Prasad N; Moss AG; Curt Bird R
    BMC Cancer; 2018 Aug; 18(1):832. PubMed ID: 30126376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A panel of eight microRNAs is a good predictive parameter for triple-negative breast cancer relapse.
    Hong HC; Chuang CH; Huang WC; Weng SL; Chen CH; Chang KH; Liao KW; Huang HD
    Theranostics; 2020; 10(19):8771-8789. PubMed ID: 32754277
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of dysregulated microRNAs associated with diagnosis and prognosis in triple‑negative breast cancer: An in silico study.
    Fan C; Liu N
    Oncol Rep; 2019 Jun; 41(6):3313-3324. PubMed ID: 30942465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.
    Yoshizawa S; Umezu T; Saitoh Y; Gotoh M; Akahane D; Kobayashi C; Ohyashiki JH; Ohyashiki K
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer.
    Zhang Z; Zhang L; Yu G; Sun Z; Wang T; Tian X; Duan X; Zhang C
    Cancer Chemother Pharmacol; 2020 Dec; 86(6):761-772. PubMed ID: 33068176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profile of serum-related exosomal miRNAs from parathyroid tumor.
    Wang J; Wang Q; Zhao T; Liu X; Bai G; Xin Y; Shen H; Wei B
    Endocrine; 2021 Apr; 72(1):239-248. PubMed ID: 33161496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Relevance of Circulating, Cell-Free and Exosomal microRNAs in Plasma and Serum of Breast Cancer Patients.
    Schwarzenbach H
    Oncol Res Treat; 2017; 40(7-8):423-429. PubMed ID: 28683441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma-Derived Exosomal hsa-miR-4488 and hsa-miR-1228-5p: Novel Biomarkers for Dermatomyositis-Associated Interstitial Lung Disease with Anti-Melanoma Differentiation-Associated Protein 5 Antibody-Positive Subset.
    Zhong D; Wu C; Xu D; Bai J; Wang Q; Zeng X
    Biomed Res Int; 2021; 2021():6676107. PubMed ID: 34368354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.